Titre : Troubles neurocognitifs

Troubles neurocognitifs : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostique-t-on un trouble neurocognitif ?

Le diagnostic repose sur l'évaluation clinique, des tests neuropsychologiques et des examens d'imagerie.
Troubles neurocognitifs Évaluation neuropsychologique
#2

Quels tests sont utilisés pour le diagnostic ?

Des tests de mémoire, d'attention et de langage sont couramment utilisés pour évaluer les fonctions cognitives.
Tests neuropsychologiques Mémoire
#3

Les antécédents médicaux sont-ils importants ?

Oui, les antécédents médicaux aident à identifier des causes sous-jacentes des troubles cognitifs.
Antécédents médicaux Évaluation clinique
#4

Peut-on diagnostiquer à un stade précoce ?

Oui, un diagnostic précoce est possible grâce à des évaluations cognitives régulières.
Diagnostic précoce Évaluation cognitive
#5

Les examens d'imagerie sont-ils nécessaires ?

Des examens comme l'IRM peuvent être nécessaires pour exclure d'autres pathologies cérébrales.
Imagerie cérébrale IRM

Symptômes 5

#1

Quels sont les symptômes courants des troubles neurocognitifs ?

Les symptômes incluent la perte de mémoire, la confusion, des difficultés de concentration et des changements de personnalité.
Symptômes Perte de mémoire
#2

La dépression est-elle un symptôme associé ?

Oui, la dépression peut accompagner les troubles neurocognitifs, affectant la cognition et l'humeur.
Dépression Troubles neurocognitifs
#3

Les troubles du langage sont-ils fréquents ?

Oui, des difficultés d'expression ou de compréhension peuvent survenir dans certains troubles neurocognitifs.
Troubles du langage Cognition
#4

Les hallucinations sont-elles possibles ?

Oui, certaines formes de troubles neurocognitifs peuvent entraîner des hallucinations visuelles ou auditives.
Hallucinations Troubles neurocognitifs
#5

Comment évoluent les symptômes ?

Les symptômes peuvent s'aggraver progressivement, affectant la vie quotidienne et l'autonomie.
Évolution des symptômes Autonomie

Prévention 5

#1

Peut-on prévenir les troubles neurocognitifs ?

Certaines mesures comme l'exercice, une alimentation saine et la stimulation cognitive peuvent aider.
Prévention Alimentation saine
#2

L'activité physique joue-t-elle un rôle ?

Oui, l'activité physique régulière est associée à un risque réduit de troubles neurocognitifs.
Activité physique Risque réduit
#3

L'éducation peut-elle aider à prévenir ?

Un niveau d'éducation plus élevé est lié à un risque réduit de développer des troubles neurocognitifs.
Éducation Risque réduit
#4

Le contrôle des maladies cardiovasculaires est-il important ?

Oui, contrôler les facteurs de risque cardiovasculaires peut réduire le risque de troubles neurocognitifs.
Maladies cardiovasculaires Facteurs de risque
#5

Les interactions sociales sont-elles bénéfiques ?

Oui, maintenir des interactions sociales actives peut contribuer à la santé cognitive.
Interactions sociales Santé cognitive

Traitements 5

#1

Quels traitements sont disponibles pour ces troubles ?

Les traitements incluent des médicaments, des thérapies cognitives et des interventions psychosociales.
Traitements Thérapies cognitives
#2

Les médicaments peuvent-ils ralentir la progression ?

Certains médicaments peuvent aider à ralentir la progression des symptômes dans certains types de troubles.
Médicaments Progression des symptômes
#3

La thérapie occupationnelle est-elle utile ?

Oui, la thérapie occupationnelle aide à maintenir l'autonomie et à améliorer la qualité de vie.
Thérapie occupationnelle Qualité de vie
#4

Les approches non médicamenteuses sont-elles efficaces ?

Oui, des approches comme la stimulation cognitive peuvent améliorer les fonctions cognitives.
Stimulation cognitive Approches non médicamenteuses
#5

Les soins de soutien sont-ils importants ?

Oui, les soins de soutien pour les patients et les familles sont cruciaux pour gérer la maladie.
Soins de soutien Gestion de la maladie

Complications 5

#1

Quelles complications peuvent survenir ?

Les complications incluent la perte d'autonomie, des troubles comportementaux et des problèmes de santé physique.
Complications Perte d'autonomie
#2

Les troubles de l'humeur sont-ils des complications ?

Oui, des troubles de l'humeur comme l'anxiété et la dépression peuvent survenir.
Troubles de l'humeur Anxiété
#3

Les chutes sont-elles un risque ?

Oui, les patients peuvent être à risque accru de chutes en raison de troubles de l'équilibre.
Chutes Troubles de l'équilibre
#4

Comment les complications affectent-elles la vie quotidienne ?

Elles peuvent rendre les activités quotidiennes difficiles, nécessitant souvent une aide extérieure.
Vie quotidienne Aide extérieure
#5

Les complications peuvent-elles affecter la famille ?

Oui, les complications peuvent également peser sur les proches, entraînant stress et épuisement.
Stress familial Épuisement

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Les facteurs incluent l'âge avancé, les antécédents familiaux et les maladies cardiovasculaires.
Facteurs de risque Âge avancé
#2

Le diabète est-il un facteur de risque ?

Oui, le diabète mal contrôlé est associé à un risque accru de troubles neurocognitifs.
Diabète Risque accru
#3

Le tabagisme influence-t-il le risque ?

Oui, le tabagisme est lié à un risque accru de déclin cognitif et de troubles neurocognitifs.
Tabagisme Déclin cognitif
#4

Le stress chronique est-il un facteur ?

Oui, le stress chronique peut contribuer à la détérioration cognitive et à l'apparition de troubles.
Stress chronique Détérioration cognitive
#5

Les traumatismes crâniens augmentent-ils le risque ?

Oui, les traumatismes crâniens répétés sont un facteur de risque pour certains troubles neurocognitifs.
Traumatismes crâniens Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Troubles neurocognitifs : Questions médicales les plus fréquentes", "headline": "Troubles neurocognitifs : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Troubles neurocognitifs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2026-08-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Troubles neurocognitifs" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles mentaux", "url": "https://questionsmedicales.fr/mesh/D001523", "about": { "@type": "MedicalCondition", "name": "Troubles mentaux", "code": { "@type": "MedicalCode", "code": "D001523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amnésie", "alternateName": "Amnesia", "url": "https://questionsmedicales.fr/mesh/D000647", "about": { "@type": "MedicalCondition", "name": "Amnésie", "code": { "@type": "MedicalCode", "code": "D000647", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amnésie antérograde", "alternateName": "Amnesia, Anterograde", "url": "https://questionsmedicales.fr/mesh/D020324", "about": { "@type": "MedicalCondition", "name": "Amnésie antérograde", "code": { "@type": "MedicalCode", "code": "D020324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.200.137" } } }, { "@type": "MedicalWebPage", "name": "Amnésie rétrograde", "alternateName": "Amnesia, Retrograde", "url": "https://questionsmedicales.fr/mesh/D000648", "about": { "@type": "MedicalCondition", "name": "Amnésie rétrograde", "code": { "@type": "MedicalCode", "code": "D000648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.200.150" } } }, { "@type": "MedicalWebPage", "name": "Amnésie globale transitoire", "alternateName": "Amnesia, Transient Global", "url": "https://questionsmedicales.fr/mesh/D020236", "about": { "@type": "MedicalCondition", "name": "Amnésie globale transitoire", "code": { "@type": "MedicalCode", "code": "D020236", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.200.800" } } } ] }, { "@type": "MedicalWebPage", "name": "Troubles de la cognition", "alternateName": "Cognition Disorders", "url": "https://questionsmedicales.fr/mesh/D003072", "about": { "@type": "MedicalCondition", "name": "Troubles de la cognition", "code": { "@type": "MedicalCode", "code": "D003072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Troubles de la perception auditive", "alternateName": "Auditory Perceptual Disorders", "url": "https://questionsmedicales.fr/mesh/D001308", "about": { "@type": "MedicalCondition", "name": "Troubles de la perception auditive", "code": { "@type": "MedicalCode", "code": "D001308", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.100" } } }, { "@type": "MedicalWebPage", "name": "Dysfonctionnement cognitif", "alternateName": "Cognitive Dysfunction", "url": "https://questionsmedicales.fr/mesh/D060825", "about": { "@type": "MedicalCondition", "name": "Dysfonctionnement cognitif", "code": { "@type": "MedicalCode", "code": "D060825", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.700" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Altération cognitive liée à la chimiothérapie", "alternateName": "Chemotherapy-Related Cognitive Impairment", "url": "https://questionsmedicales.fr/mesh/D000084202", "about": { "@type": "MedicalCondition", "name": "Altération cognitive liée à la chimiothérapie", "code": { "@type": "MedicalCode", "code": "D000084202", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.700.250" } } }, { "@type": "MedicalWebPage", "name": "Complications post-opératoires cognitives", "alternateName": "Postoperative Cognitive Complications", "url": "https://questionsmedicales.fr/mesh/D000079690", "about": { "@type": "MedicalCondition", "name": "Complications post-opératoires cognitives", "code": { "@type": "MedicalCode", "code": "D000079690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.700.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Altération cognitive liée à la chimiothérapie", "alternateName": "Chemotherapy-Related Cognitive Impairment", "url": "https://questionsmedicales.fr/mesh/D000084202", "about": { "@type": "MedicalCondition", "name": "Altération cognitive liée à la chimiothérapie", "code": { "@type": "MedicalCode", "code": "D000084202", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.700.250" } } }, { "@type": "MedicalWebPage", "name": "Complications post-opératoires cognitives", "alternateName": "Postoperative Cognitive Complications", "url": "https://questionsmedicales.fr/mesh/D000079690", "about": { "@type": "MedicalCondition", "name": "Complications post-opératoires cognitives", "code": { "@type": "MedicalCode", "code": "D000079690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.250.700.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Troubles de la conscience", "alternateName": "Consciousness Disorders", "url": "https://questionsmedicales.fr/mesh/D003244", "about": { "@type": "MedicalCondition", "name": "Troubles de la conscience", "code": { "@type": "MedicalCode", "code": "D003244", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.300" } } }, { "@type": "MedicalWebPage", "name": "Délire avec confusion", "alternateName": "Delirium", "url": "https://questionsmedicales.fr/mesh/D003693", "about": { "@type": "MedicalCondition", "name": "Délire avec confusion", "code": { "@type": "MedicalCode", "code": "D003693", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.350" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Délire d'émergence", "alternateName": "Emergence Delirium", "url": "https://questionsmedicales.fr/mesh/D000071257", "about": { "@type": "MedicalCondition", "name": "Délire d'émergence", "code": { "@type": "MedicalCode", "code": "D000071257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.350.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Démence", "alternateName": "Dementia", "url": "https://questionsmedicales.fr/mesh/D003704", "about": { "@type": "MedicalCondition", "name": "Démence", "code": { "@type": "MedicalCode", "code": "D003704", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Démence associée au SIDA", "alternateName": "AIDS Dementia Complex", "url": "https://questionsmedicales.fr/mesh/D015526", "about": { "@type": "MedicalCondition", "name": "Démence associée au SIDA", "code": { "@type": "MedicalCode", "code": "D015526", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.050" } } }, { "@type": "MedicalWebPage", "name": "Maladie d'Alzheimer", "alternateName": "Alzheimer Disease", "url": "https://questionsmedicales.fr/mesh/D000544", "about": { "@type": "MedicalCondition", "name": "Maladie d'Alzheimer", "code": { "@type": "MedicalCode", "code": "D000544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.100" } } }, { "@type": "MedicalWebPage", "name": "Aphasie progressive primaire", "alternateName": "Aphasia, Primary Progressive", "url": "https://questionsmedicales.fr/mesh/D018888", "about": { "@type": "MedicalCondition", "name": "Aphasie progressive primaire", "code": { "@type": "MedicalCode", "code": "D018888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.125" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Creutzfeldt-Jakob", "alternateName": "Creutzfeldt-Jakob Syndrome", "url": "https://questionsmedicales.fr/mesh/D007562", "about": { "@type": "MedicalCondition", "name": "Maladie de Creutzfeldt-Jakob", "code": { "@type": "MedicalCode", "code": "D007562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.300" } } }, { "@type": "MedicalWebPage", "name": "Démence vasculaire", "alternateName": "Dementia, Vascular", "url": "https://questionsmedicales.fr/mesh/D015140", "about": { "@type": "MedicalCondition", "name": "Démence vasculaire", "code": { "@type": "MedicalCode", "code": "D015140", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.350" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Démence par infarctus multiples", "alternateName": "Dementia, Multi-Infarct", "url": "https://questionsmedicales.fr/mesh/D015161", "about": { "@type": "MedicalCondition", "name": "Démence par infarctus multiples", "code": { "@type": "MedicalCode", "code": "D015161", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.350.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Démence par infarctus multiples", "alternateName": "Dementia, Multi-Infarct", "url": "https://questionsmedicales.fr/mesh/D015161", "about": { "@type": "MedicalCondition", "name": "Démence par infarctus multiples", "code": { "@type": "MedicalCode", "code": "D015161", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.350.400" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Kosaka-Shibayama", "alternateName": "Diffuse Neurofibrillary Tangles with Calcification", "url": "https://questionsmedicales.fr/mesh/D055956", "about": { "@type": "MedicalCondition", "name": "Maladie de Kosaka-Shibayama", "code": { "@type": "MedicalCode", "code": "D055956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.370" } } }, { "@type": "MedicalWebPage", "name": "Dégénérescence lobaire frontotemporale", "alternateName": "Frontotemporal Lobar Degeneration", "url": "https://questionsmedicales.fr/mesh/D057174", "about": { "@type": "MedicalCondition", "name": "Dégénérescence lobaire frontotemporale", "code": { "@type": "MedicalCode", "code": "D057174", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Démence frontotemporale", "alternateName": "Frontotemporal Dementia", "url": "https://questionsmedicales.fr/mesh/D057180", "about": { "@type": "MedicalCondition", "name": "Démence frontotemporale", "code": { "@type": "MedicalCode", "code": "D057180", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Démence de Pick", "alternateName": "Pick Disease of the Brain", "url": "https://questionsmedicales.fr/mesh/D020774", "about": { "@type": "MedicalCondition", "name": "Démence de Pick", "code": { "@type": "MedicalCode", "code": "D020774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Démence de Pick", "alternateName": "Pick Disease of the Brain", "url": "https://questionsmedicales.fr/mesh/D020774", "about": { "@type": "MedicalCondition", "name": "Démence de Pick", "code": { "@type": "MedicalCode", "code": "D020774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299.500" } } }, { "@type": "MedicalWebPage", "name": "Aphasie primaire progressive non fluente", "alternateName": "Primary Progressive Nonfluent Aphasia", "url": "https://questionsmedicales.fr/mesh/D057178", "about": { "@type": "MedicalCondition", "name": "Aphasie primaire progressive non fluente", "code": { "@type": "MedicalCode", "code": "D057178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Démence frontotemporale", "alternateName": "Frontotemporal Dementia", "url": "https://questionsmedicales.fr/mesh/D057180", "about": { "@type": "MedicalCondition", "name": "Démence frontotemporale", "code": { "@type": "MedicalCode", "code": "D057180", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Démence de Pick", "alternateName": "Pick Disease of the Brain", "url": "https://questionsmedicales.fr/mesh/D020774", "about": { "@type": "MedicalCondition", "name": "Démence de Pick", "code": { "@type": "MedicalCode", "code": "D020774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Démence de Pick", "alternateName": "Pick Disease of the Brain", "url": "https://questionsmedicales.fr/mesh/D020774", "about": { "@type": "MedicalCondition", "name": "Démence de Pick", "code": { "@type": "MedicalCode", "code": "D020774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.299.500" } } }, { "@type": "MedicalWebPage", "name": "Aphasie primaire progressive non fluente", "alternateName": "Primary Progressive Nonfluent Aphasia", "url": "https://questionsmedicales.fr/mesh/D057178", "about": { "@type": "MedicalCondition", "name": "Aphasie primaire progressive non fluente", "code": { "@type": "MedicalCode", "code": "D057178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.380.600" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Huntington", "alternateName": "Huntington Disease", "url": "https://questionsmedicales.fr/mesh/D006816", "about": { "@type": "MedicalCondition", "name": "Maladie de Huntington", "code": { "@type": "MedicalCode", "code": "D006816", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.390" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Klüver-Bucy", "alternateName": "Kluver-Bucy Syndrome", "url": "https://questionsmedicales.fr/mesh/D020232", "about": { "@type": "MedicalCondition", "name": "Syndrome de Klüver-Bucy", "code": { "@type": "MedicalCode", "code": "D020232", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.431" } } }, { "@type": "MedicalWebPage", "name": "Maladie à corps de Lewy", "alternateName": "Lewy Body Disease", "url": "https://questionsmedicales.fr/mesh/D020961", "about": { "@type": "MedicalCondition", "name": "Maladie à corps de Lewy", "code": { "@type": "MedicalCode", "code": "D020961", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.512" } } }, { "@type": "MedicalWebPage", "name": "Démences mixtes", "alternateName": "Mixed Dementias", "url": "https://questionsmedicales.fr/mesh/D000093902", "about": { "@type": "MedicalCondition", "name": "Démences mixtes", "code": { "@type": "MedicalCode", "code": "D000093902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.400.756" } } } ] }, { "@type": "MedicalWebPage", "name": "Alexie pure", "alternateName": "Alexia, Pure", "url": "https://questionsmedicales.fr/mesh/D020237", "about": { "@type": "MedicalCondition", "name": "Alexie pure", "code": { "@type": "MedicalCode", "code": "D020237", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.615.700.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Troubles neurocognitifs", "alternateName": "Neurocognitive Disorders", "code": { "@type": "MedicalCode", "code": "D019965", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Niccolò Terrando", "url": "https://questionsmedicales.fr/author/Niccol%C3%B2%20Terrando", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Philippe Robert", "url": "https://questionsmedicales.fr/author/Philippe%20Robert", "affiliation": { "@type": "Organization", "name": "Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France." } }, { "@type": "Person", "name": "Valeria Manera", "url": "https://questionsmedicales.fr/author/Valeria%20Manera", "affiliation": { "@type": "Organization", "name": "Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France." } }, { "@type": "Person", "name": "Lisbeth A Evered", "url": "https://questionsmedicales.fr/author/Lisbeth%20A%20Evered", "affiliation": { "@type": "Organization", "name": "Department of Critical Care, School of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesia and Acute Pain Medicine, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia; Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA." } }, { "@type": "Person", "name": "Kannayiram Alagiakrishnan", "url": "https://questionsmedicales.fr/author/Kannayiram%20Alagiakrishnan", "affiliation": { "@type": "Organization", "name": "Division of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Postoperative neurocognitive disorders: A clinical guide.", "datePublished": "2023-11-08", "url": "https://questionsmedicales.fr/article/37944401", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jclinane.2023.111320" } }, { "@type": "ScholarlyArticle", "name": "Systemic inflammation, neuroinflammation and perioperative neurocognitive disorders.", "datePublished": "2023-09-09", "url": "https://questionsmedicales.fr/article/37688642", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00011-023-01792-2" } }, { "@type": "ScholarlyArticle", "name": "CNVDeep: deep association of copy number variants with neurocognitive disorders.", "datePublished": "2024-08-29", "url": "https://questionsmedicales.fr/article/39210319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-024-05874-8" } }, { "@type": "ScholarlyArticle", "name": "TEGEST as promising tool for assessing the risk of perioperative neurocognitive disorders.", "datePublished": "2024-08-28", "url": "https://questionsmedicales.fr/article/39198728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12877-024-05302-9" } }, { "@type": "ScholarlyArticle", "name": "The potential mechanism of mitochondrial homeostasis in postoperative neurocognitive disorders: an in-depth review.", "datePublished": "2024-10-25", "url": "https://questionsmedicales.fr/article/39450938", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/07853890.2024.2411012" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles neurocognitifs", "item": "https://questionsmedicales.fr/mesh/D019965" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Troubles neurocognitifs - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Troubles neurocognitifs", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-09-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Troubles neurocognitifs", "description": "Comment diagnostique-t-on un trouble neurocognitif ?\nQuels tests sont utilisés pour le diagnostic ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on diagnostiquer à un stade précoce ?\nLes examens d'imagerie sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Troubles neurocognitifs", "description": "Quels sont les symptômes courants des troubles neurocognitifs ?\nLa dépression est-elle un symptôme associé ?\nLes troubles du langage sont-ils fréquents ?\nLes hallucinations sont-elles possibles ?\nComment évoluent les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Troubles neurocognitifs", "description": "Peut-on prévenir les troubles neurocognitifs ?\nL'activité physique joue-t-elle un rôle ?\nL'éducation peut-elle aider à prévenir ?\nLe contrôle des maladies cardiovasculaires est-il important ?\nLes interactions sociales sont-elles bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Troubles neurocognitifs", "description": "Quels traitements sont disponibles pour ces troubles ?\nLes médicaments peuvent-ils ralentir la progression ?\nLa thérapie occupationnelle est-elle utile ?\nLes approches non médicamenteuses sont-elles efficaces ?\nLes soins de soutien sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Troubles neurocognitifs", "description": "Quelles complications peuvent survenir ?\nLes troubles de l'humeur sont-ils des complications ?\nLes chutes sont-elles un risque ?\nComment les complications affectent-elles la vie quotidienne ?\nLes complications peuvent-elles affecter la famille ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Troubles neurocognitifs", "description": "Quels sont les principaux facteurs de risque ?\nLe diabète est-il un facteur de risque ?\nLe tabagisme influence-t-il le risque ?\nLe stress chronique est-il un facteur ?\nLes traumatismes crâniens augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D019965#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un trouble neurocognitif ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique, des tests neuropsychologiques et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de mémoire, d'attention et de langage sont couramment utilisés pour évaluer les fonctions cognitives." } }, { "@type": "Question", "name": "Les antécédents médicaux sont-ils importants ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents médicaux aident à identifier des causes sous-jacentes des troubles cognitifs." } }, { "@type": "Question", "name": "Peut-on diagnostiquer à un stade précoce ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce est possible grâce à des évaluations cognitives régulières." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des examens comme l'IRM peuvent être nécessaires pour exclure d'autres pathologies cérébrales." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles neurocognitifs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la perte de mémoire, la confusion, des difficultés de concentration et des changements de personnalité." } }, { "@type": "Question", "name": "La dépression est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dépression peut accompagner les troubles neurocognitifs, affectant la cognition et l'humeur." } }, { "@type": "Question", "name": "Les troubles du langage sont-ils fréquents ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés d'expression ou de compréhension peuvent survenir dans certains troubles neurocognitifs." } }, { "@type": "Question", "name": "Les hallucinations sont-elles possibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de troubles neurocognitifs peuvent entraîner des hallucinations visuelles ou auditives." } }, { "@type": "Question", "name": "Comment évoluent les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver progressivement, affectant la vie quotidienne et l'autonomie." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles neurocognitifs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures comme l'exercice, une alimentation saine et la stimulation cognitive peuvent aider." } }, { "@type": "Question", "name": "L'activité physique joue-t-elle un rôle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activité physique régulière est associée à un risque réduit de troubles neurocognitifs." } }, { "@type": "Question", "name": "L'éducation peut-elle aider à prévenir ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un niveau d'éducation plus élevé est lié à un risque réduit de développer des troubles neurocognitifs." } }, { "@type": "Question", "name": "Le contrôle des maladies cardiovasculaires est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, contrôler les facteurs de risque cardiovasculaires peut réduire le risque de troubles neurocognitifs." } }, { "@type": "Question", "name": "Les interactions sociales sont-elles bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir des interactions sociales actives peut contribuer à la santé cognitive." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces troubles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des thérapies cognitives et des interventions psychosociales." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils ralentir la progression ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent aider à ralentir la progression des symptômes dans certains types de troubles." } }, { "@type": "Question", "name": "La thérapie occupationnelle est-elle utile ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie occupationnelle aide à maintenir l'autonomie et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les approches non médicamenteuses sont-elles efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des approches comme la stimulation cognitive peuvent améliorer les fonctions cognitives." } }, { "@type": "Question", "name": "Les soins de soutien sont-ils importants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les soins de soutien pour les patients et les familles sont cruciaux pour gérer la maladie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte d'autonomie, des troubles comportementaux et des problèmes de santé physique." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'humeur comme l'anxiété et la dépression peuvent survenir." } }, { "@type": "Question", "name": "Les chutes sont-elles un risque ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être à risque accru de chutes en raison de troubles de l'équilibre." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la vie quotidienne ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent rendre les activités quotidiennes difficiles, nécessitant souvent une aide extérieure." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la famille ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent également peser sur les proches, entraînant stress et épuisement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète mal contrôlé est associé à un risque accru de troubles neurocognitifs." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est lié à un risque accru de déclin cognitif et de troubles neurocognitifs." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à la détérioration cognitive et à l'apparition de troubles." } }, { "@type": "Question", "name": "Les traumatismes crâniens augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens répétés sont un facteur de risque pour certains troubles neurocognitifs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 17/08/2026

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

29 au total
└─

Amnésie

Amnesia D000647 - F03.615.200
└─

Troubles de la cognition

Cognition Disorders D003072 - F03.615.250
└─

Troubles de la conscience

Consciousness Disorders D003244 - F03.615.300
└─

Délire avec confusion

Delirium D003693 - F03.615.350
└─

Démence

Dementia D003704 - F03.615.400
└─└─

Amnésie antérograde

Amnesia, Anterograde D020324 - F03.615.200.137
└─└─

Amnésie rétrograde

Amnesia, Retrograde D000648 - F03.615.200.150
└─└─

Amnésie globale transitoire

Amnesia, Transient Global D020236 - F03.615.200.800
└─└─

Troubles de la perception auditive

Auditory Perceptual Disorders D001308 - F03.615.250.100
└─└─

Dysfonctionnement cognitif

Cognitive Dysfunction D060825 - F03.615.250.700
└─└─

Délire d'émergence

Emergence Delirium D000071257 - F03.615.350.500
└─└─

Démence associée au SIDA

AIDS Dementia Complex D015526 - F03.615.400.050
└─└─

Maladie d'Alzheimer

Alzheimer Disease D000544 - F03.615.400.100
└─└─

Aphasie progressive primaire

Aphasia, Primary Progressive D018888 - F03.615.400.125
└─└─

Maladie de Creutzfeldt-Jakob

Creutzfeldt-Jakob Syndrome D007562 - F03.615.400.300
└─└─

Démence vasculaire

Dementia, Vascular D015140 - F03.615.400.350
└─└─

Maladie de Kosaka-Shibayama

Diffuse Neurofibrillary Tangles with Calcification D055956 - F03.615.400.370
└─└─

Dégénérescence lobaire frontotemporale

Frontotemporal Lobar Degeneration D057174 - F03.615.400.380
└─└─

Maladie de Huntington

Huntington Disease D006816 - F03.615.400.390
└─└─

Syndrome de Klüver-Bucy

Kluver-Bucy Syndrome D020232 - F03.615.400.431
└─└─

Maladie à corps de Lewy

Lewy Body Disease D020961 - F03.615.400.512
└─└─

Démences mixtes

Mixed Dementias D000093902 - F03.615.400.756
└─└─

Alexie pure

Alexia, Pure D020237 - F03.615.700.500
└─└─└─

Altération cognitive liée à la chimiothérapie

Chemotherapy-Related Cognitive Impairment D000084202 - F03.615.250.700.250
└─└─└─

Complications post-opératoires cognitives

Postoperative Cognitive Complications D000079690 - F03.615.250.700.500
└─└─└─

Démence par infarctus multiples

Dementia, Multi-Infarct D015161 - F03.615.400.350.400
└─└─└─

Démence frontotemporale

Frontotemporal Dementia D057180 - F03.615.400.380.299
└─└─└─

Aphasie primaire progressive non fluente

Primary Progressive Nonfluent Aphasia D057178 - F03.615.400.380.600
└─└─└─└─

Démence de Pick

Pick Disease of the Brain D020774 - F03.615.400.380.299.500

Auteurs principaux

Niccolò Terrando

2 publications dans cette catégorie

Philippe Robert

2 publications dans cette catégorie

Affiliations :
  • Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.
  • Association Innovation Alzheimer, Nice, France.
  • Centre Memoire, Centre Hospitalier Universitaire de Nice, Nice, France.
Publications dans "Troubles neurocognitifs" :

Valeria Manera

2 publications dans cette catégorie

Affiliations :
  • Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.
  • Association Innovation Alzheimer, Nice, France.
Publications dans "Troubles neurocognitifs" :

Lisbeth A Evered

2 publications dans cette catégorie

Affiliations :
  • Department of Critical Care, School of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesia and Acute Pain Medicine, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia; Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Troubles neurocognitifs" :

Kannayiram Alagiakrishnan

2 publications dans cette catégorie

Affiliations :
  • Division of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Publications dans "Troubles neurocognitifs" :

Tyler Halverson

2 publications dans cette catégorie

Affiliations :
  • Division of Psychiatry, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Publications dans "Troubles neurocognitifs" :

Wenguo Fan

2 publications dans cette catégorie

Affiliations :
  • Department of Anesthesiology, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
Publications dans "Troubles neurocognitifs" :

Fang Huang

2 publications dans cette catégorie

Affiliations :
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
Publications dans "Troubles neurocognitifs" :

Cornelia Knaak

2 publications dans cette catégorie

Publications dans "Troubles neurocognitifs" :

Claudia Spies

2 publications dans cette catégorie

Publications dans "Troubles neurocognitifs" :

Mervyn Maze

2 publications dans cette catégorie

Henry Brodaty

2 publications dans cette catégorie

Publications dans "Troubles neurocognitifs" :

Sean B Rourke

2 publications dans cette catégorie

Affiliations :
  • MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Eling D de Bruin

2 publications dans cette catégorie

Affiliations :
  • Department of Health Sciences and Technology, Institute of Human Movement Sciences and Sport, ETH Zürich, Zürich, Switzerland.
  • Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institute, Stockholm, Sweden.
Publications dans "Troubles neurocognitifs" :

Masaru Mimura

1 publication dans cette catégorie

Affiliations :
  • Department of Neuropsychiatry, Keio University School of Medicine.
Publications dans "Troubles neurocognitifs" :

Setayesh Reza Tasbihgou

1 publication dans cette catégorie

Affiliations :
  • Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publications dans "Troubles neurocognitifs" :

Anthony Ray Absalom

1 publication dans cette catégorie

Affiliations :
  • Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publications dans "Troubles neurocognitifs" :

Stuart Connal

1 publication dans cette catégorie

Affiliations :
  • Central London School of Anaesthesia, London, UK.
Publications dans "Troubles neurocognitifs" :

Cynthia Olotu

1 publication dans cette catégorie

Affiliations :
  • Department of Anaesthesiology, University Medical Center Hamburg, Hamburg, Germany.
Publications dans "Troubles neurocognitifs" :

C Moderie

1 publication dans cette catégorie

Affiliations :
  • Département de psychiatrie, université McGill, Montréal, Québec, Canada.
Publications dans "Troubles neurocognitifs" :

Sources (10000 au total)

CNVDeep: deep association of copy number variants with neurocognitive disorders.

Copy number variants (CNVs) have become increasingly instrumental in understanding the etiology of all diseases and phenotypes, including Neurocognitive Disorders (NDs). Among the well-established reg... In this study, we propose a regularized deep learning model to select causal regions for the target disease. With the help of the proximal [20] gradient descent algorithm, the model utilizes the group... Our model effectively identifies regions associated with phenotypic traits using regularized deep learning. Rather than attempting to analyze the whole genome, CNVDeep allows us to focus only on the c...

TEGEST as promising tool for assessing the risk of perioperative neurocognitive disorders.

Perioperative neurocognitive disorders are often neglected and undiagnosed. There are known risk factors for these disorders (e.g., higher levels of frailty, cognitive decline before surgery). However... This was a prospective, monocentric, observational study that included one cohort of patients aged 65 years and older. Patients underwent acute or elective surgical operations. Preanaesthesia tests we... This study included 164 patients. The arithmetic mean age was 74.5 years. The strongest correlations were observed between MMSE scores and TEGEST scores (r = 0.830 before and 0.786 after surgery, P < ... According to our results, the TEGEST is a suitable option for assessing cognitive functioning before surgery among patients who are at risk of developing perioperative neurocognitive disorders. This s...

Association between cerebrovascular disease and perioperative neurocognitive disorders: a retrospective cohort study.

Previous studies have shown that patients with cerebrovascular disease (CVD) have a significantly increased risk of cognitive decline or dementia; however, the association between preoperative CVD and... This retrospective cohort study evaluated 13 899 surgical patients of a large-scale comprehensive hospital between January 2021 and January 2022 to explore the association between preoperative CVD and... Of the included 13 899 patients, propensity score matching yielded 1006 patient pairs. Multivariate logistic regression analysis revealed that CVD was an independent risk factor for PNDs [odds ratio: ... CVD was an independent risk factor for PNDs and affected the overall postoperative survival rate of surgical patients with preoperative CVD....

The use of technology by seniors with neurocognitive disorders in long-term care: a scoping review.

To map the current state of knowledge about the use of technology with seniors with neurocognitive disorders in long-term care to foster interactions, wellness, and stimulation.... Cumulative Index to Nursing and Allied Health Literature (CINAHL Plus); MEDLINE; PsycINFO; Embase and Web of Science were searched in eligible literature, with no limit of time, to describe the curren... The search yielded 3,605 studies, of which 39 were included. Most technology type reported was robotics. Included studies reports different positive effects on the use of such technology such as incre... The study highlights different types and potential benefits of technology for long-term care residents with neurocognitive disorders, emphasizing the crucial need for additional research to refine int...

Association between anaesthesia-related factors and postoperative neurocognitive disorder: a post-hoc analysis.

Postoperative neurocognitive disorder (pNCD) is common after surgery. Exposure to anaesthetic drugs has been implicated as a potential cause of pNCD. Although several studies have investigated risk fa... We analysed data obtained for a prospective observational study in patients aged ≥ 65 years who underwent surgery for excision of a solid tumour. Cognitive function was assessed preoperatively and at ... Of the 196 included patients, 23 (12%) fulfilled the criteria for pNCD at 3 months postoperatively. A low preoperative score on Mini-Mental State Examination (OR, 8.9 [95% CI, (2.8-27.9)], p < 0.001) ... In this cohort, duration of anaesthesia, which is probably an expression of the complexity of the surgery, was the only anaesthesia-related predictor of pNCD. On average, patients' scores on cognitive...

The characteristics of cognitive and daily living functions of neurocognitive disorders with delusions in elderly Alzheimer's disease.

Delusions in neurocognitive disorder due to Alzheimer's disease (AD) worsen patients' cognitive functions and activities of daily living (ADL), increasing caregiver burden and the risk of mortality. A... We compared cognitive function and ADL in AD patients aged 65 years or older according to the presence of delusions. To assess longitudinal change, we analyzed data from patients monitored for an aver... The delusions group exhibited poorer immediate recall of verbal memory than the non-delusions group. In the follow-up evaluation, patients who developed delusions had lower baseline cognitive function... While controlling for the severity of AD, we found no significant negative impacts of delusions on most cognitive functions. Nevertheless, it is noteworthy that the immediate recall of verbal memory a...